Meeting
2023 ASCO Annual Meeting
Elevated cancer risk among individuals with combinations of cancer-related risk factors: A large claims database analysis.
Authors
Ze Cong
GRAIL, LLC, a subsidiary of Illumina, Inc., currently held separate from Illumina, Inc., under the terms of the Interim Measures Order of the European Commission dated 29 October 2021, Menlo Park, CA
Ze Cong , Xiangyang Ye , Allison W. Kurian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10561)
DOI
10.1200/JCO.2023.41.16_suppl.10561
Abstract #
10561
Poster Bd #
194
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Development and external validation of a melanoma risk prediction model using self-assessed risk factors.
First Author: Kylie Vuong
Poster
2012 Gastrointestinal Cancers Symposium
Staging of advanced hepatocellular carcinoma patients in the targeted therapy era.
First Author: Neeraj Nailesh Shah
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prevalence of modifiable risk factors of Hispanic adult patients admitted with gastric cancer in the US.
First Author: Alejandro Nieto Dominguez
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Preoperative risk factors related to relapse-free survival after R0 resection of gallbladder cancer.
First Author: Sang Hun Lee